Caitlin A.Bell


Cleveland + 1.216.586.7584

Caitlin Bell advises clients on compliance, civil litigation, and white-collar criminal matters. She has experience representing businesses, boards of directors, and senior management in relation to a wide range of compliance issues. Caitlin has counseled clients regarding the development, enhancement, and maintenance of effective international corporate compliance programs; addressing compliance issues to avoid governmental sanctions; and compliance with anticorruption laws, including the Foreign Corrupt Practices Act. She also has experience conducting internal investigations into allegations of fraud, corruption, and other misconduct and assisting clients with pre- and post-acquisition anticorruption compliance due diligence.

Caitlin's practice also includes representing public and private organizations in civil matters in both state and federal courts. She has experience assisting clients in commercial litigation, contract disputes, and shareholder litigation. In addition, Caitlin has experience defending clients with respect to government investigations and enforcement actions involving allegations of bribery, fraud, and other wrongdoing.

Caitlin recently served as a trustee on the Cleveland Metropolitan Bar Association's Board of Trustees. She is also an adjunct professor of law at Case Western Reserve University, where she teaches a course on white-collar crime.


  • Parker Hannifin acquires Exotic Metals Forming Company LLC for $1.725 billion cashJones Day advised Parker Hannifin Corporation in its $1.725 billion cash acquisition of Exotic Metals Forming Company LLC.
  • Manufacturing company assesses and reconfigures compliance programAt the request of the Board of Directors of a public manufacturing company in the food industry, Jones Day assessed the company's existing compliance program.
  • STERIS defends challenge to certain payments made in "inversion" merger with UK companyJones Day represented STERIS Corporation and its directors and officers in an action in Ohio state court (settled) alleging breaches of fiduciary duty in authorizing tax gross-up (or make-whole) payments designed to address tax penalties imposed in connection with corporate combinations that shift headquarters overseas.
  • Cardinal Health acquires Cordis for $1.9 billionJones Day advised Cardinal Health, Inc. in its acquisition of Johnson & Johnson's Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.9 billion in cash.
  • Cardinal Health acquires The Harvard Drug Group for $1.115 billionJones Day advised Cardinal Health in its acquisition of The Harvard Drug Group, a distributor of generic pharmaceuticals, over-the-counter medications, and related products to retail, institutional, and alternate care customers from Court Square Capital Partners for $1.115 billion.
  • Speaking Engagements

    • November 28, 2017
      Compliance Today: Benchmarking and Practical Insights, Jones Day CLE Academy 2017
    • December 12, 2014
      White Collar Crime in America and the World: Preventing, Detecting, & Remediating Wrongful Conduct, seminar co-chair, Cleveland Metropolitan Bar Association Biennial Institute on White Collar Crime (
    • December 3, 2013
      International Investigations in the Age of the Whistleblower: Views from Around the World, Jones Day CLE Academy 2013